BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26881831)

  • 1. Pediatric Chordomas: A Population-Based Clinical Outcome Study Involving 86 Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (1973-2011).
    Lau CS; Mahendraraj K; Ward A; Chamberlain RS
    Pediatr Neurosurg; 2016; 51(3):127-36. PubMed ID: 26881831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014.
    Pan Y; Lu L; Chen J; Zhong Y; Dai Z
    J Orthop Surg Res; 2018 Apr; 13(1):76. PubMed ID: 29625617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
    Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chordomas of the Skull Base, Mobile Spine, and Sacrum: An Epidemiologic Investigation of Presentation, Treatment, and Survival.
    Zuckerman SL; Bilsky MH; Laufer I
    World Neurosurg; 2018 May; 113():e618-e627. PubMed ID: 29486315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and relative survival of chordomas: the standardized mortality ratio and the impact of chordomas on a population.
    Smoll NR; Gautschi OP; Radovanovic I; Schaller K; Weber DC
    Cancer; 2013 Jun; 119(11):2029-37. PubMed ID: 23504991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease outcomes for skull base and spinal chordomas: a single center experience.
    Ahmed R; Sheybani A; Menezes AH; Buatti JM; Hitchon PW
    Clin Neurol Neurosurg; 2015 Mar; 130():67-73. PubMed ID: 25590662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and patterns of care in adult skull base chordomas from the Surveillance, Epidemiology, and End Results (SEER) database.
    Jones PS; Aghi MK; Muzikansky A; Shih HA; Barker FG; Curry WT
    J Clin Neurosci; 2014 Sep; 21(9):1490-6. PubMed ID: 24852903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis.
    Bohman LE; Koch M; Bailey RL; Alonso-Basanta M; Lee JY
    World Neurosurg; 2014 Nov; 82(5):806-14. PubMed ID: 25009165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Factors and Survival Outcome in Patients with Chordoma in the United States: A Population-Based Analysis.
    Lee IJ; Lee RJ; Fahim DK
    World Neurosurg; 2017 Aug; 104():346-355. PubMed ID: 28457925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chordoma].
    George B; Bresson D; Bouazza S; Froelich S; Mandonnet E; Hamdi S; Orabi M; Polivka M; Cazorla A; Adle-Biassette H; Guichard JP; Duet M; Gayat E; Vallée F; Canova CH; Riet F; Bolle S; Calugaru V; Dendale R; Mazeron JJ; Feuvret L; Boissier E; Vignot S; Puget S; Sainte-Rose C; Beccaria K
    Neurochirurgie; 2014 Jun; 60(3):63-140. PubMed ID: 24856008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes following attempted en bloc resection of cervical chordomas in the C-1 and C-2 region versus the subaxial region: a multiinstitutional experience.
    Molina CA; Ames CP; Chou D; Rhines LD; Hsieh PC; Zadnik PL; Wolinsky JP; Gokaslan ZL; Sciubba DM
    J Neurosurg Spine; 2014 Sep; 21(3):348-56. PubMed ID: 24926926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors.
    Rotondo RL; Folkert W; Liebsch NJ; Chen YL; Pedlow FX; Schwab JH; Rosenberg AE; Nielsen GP; Szymonifka J; Ferreira AE; Hornicek FJ; DeLaney TF
    J Neurosurg Spine; 2015 Dec; 23(6):788-97. PubMed ID: 26340383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does insulin-like growth factor 1 receptor (IGF-1R) targeting provide new treatment options for chordomas? A retrospective clinical and immunohistochemical study.
    Scheipl S; Froehlich EV; Leithner A; Beham A; Quehenberger F; Mokry M; Stammberger H; Varga PP; Lazáry A; Windhager R; Gattenloehner S; Liegl B
    Histopathology; 2012 May; 60(6):999-1003. PubMed ID: 22372631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of ezrin, MMP-9, and COX-2 in 50 chordoma specimens: a clinical and immunohistochemical analysis.
    Froehlich EV; Scheipl S; Lazàry A; Varga PP; Schmid C; Stammberger H; Beham A; Bodo K; Schroettner H; Quehenberger F; Windhager R; Liegl B; Leithner A
    Spine (Phila Pa 1976); 2012 Jun; 37(13):E757-67. PubMed ID: 22228328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical findings in families with chordoma with and without T gene duplications and in patients with sporadic chordoma reported to the Surveillance, Epidemiology, and End Results program.
    Parry DM; McMaster ML; Liebsch NJ; Patronas NJ; Quezado MM; Zametkin D; Yang XR; Goldstein AM
    J Neurosurg; 2020 Jun; 134(5):1399-1408. PubMed ID: 32559743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival analysis of patients with spinal chordomas.
    Sun HH; Hong X; Liu B; Cui JQ; Zhou ZM; Xie XH; Wu XT
    Neurosurg Rev; 2019 Jun; 42(2):455-462. PubMed ID: 29732516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sacral Chordoma: A Population-based Analysis of Epidemiology and Survival Outcomes.
    Scampa M; Tessitore E; Dominguez DE; Hannouche D; Buchs NC; Kalbermatten DF; Oranges CM
    Anticancer Res; 2022 Feb; 42(2):929-937. PubMed ID: 35093892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients.
    Hsieh PC; Xu R; Sciubba DM; McGirt MJ; Nelson C; Witham TF; Wolinksy JP; Gokaslan ZL
    Spine (Phila Pa 1976); 2009 Sep; 34(20):2233-9. PubMed ID: 19752710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and histopathologic features of chordomas in children and young adults.
    Ridenour RV; Ahrens WA; Folpe AL; Miller DV
    Pediatr Dev Pathol; 2010; 13(1):9-17. PubMed ID: 19348512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine kinase receptor expression in chordomas: phosphorylated AKT correlates inversely with outcome.
    de Castro CV; Guimaraes G; Aguiar S; Lopes A; Baiocchi G; da Cunha IW; Campos AH; Soares FA; Begnami MD
    Hum Pathol; 2013 Sep; 44(9):1747-55. PubMed ID: 23618355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.